4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-15-000033
CEO bought 15,000 shares at an average $0.17 ($2,475)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-07-16 | Purchase : show line 1 in the form | +5,000 | $0.17 | $850 | 4,526,580 | D |
| 2015-07-17 | Purchase : show line 2 in the form | +5,000 | $0.16 | $800 | 4,531,580 | D |
| 2015-07-17 | Purchase : show line 3 in the form | +5,000 | $0.17 | $825 | 4,536,580 | D |
| Open-market purchases · 15,000 sh · avg $0.17 · $2,475 | ||||||
Loading xslF345X03/primary_doc.xml…